Reaching a diagnosis in congenital metabolic disorders using neuroimaging;Aproximacion al diagnostico de los errores congenitos del metabolismo por la neuroimagen

Revista de Neurologia

Volumn 28, Issue 1, 1999, Pages 16-23

  Campistol, J ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

Brain malformations; Inherited metabolic diseases; Neuroimaging; Spectroscopy MR

Indexed keywords

BRAIN MALFORMATION; BRAIN SCINTISCANNING; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; HUMAN; METABOLIC DISORDER; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW; BRAIN; COMPUTER ASSISTED TOMOGRAPHY; CONGENITAL MALFORMATION; INBORN ERROR OF METABOLISM; PATHOLOGY; RADIOGRAPHY;

BRAIN; HUMANS; MAGNETIC RESONANCE IMAGING; METABOLISM, INBORN ERRORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0033556566     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.2801.98342     Document Type: Review

References (22)

1. Barkovich AJ, Pediatric Neuroimaging. 2 ed. New York: Raven Press; 1996.
2. Campistol J. Enfermedades metabólicas de presentación neonatal. Editorial. Arch Pediatr 1995; 46: 115-7.
3. Gili J, Capdevila A. Resonancia magnética. Barcelona: Centre Diagnòstic Pedralbes; 1993.
4. Grodd N, Krägeloh-Mann I, Klose V, Sauter R. Metabolic and destructive brain disorders in children: findings with localized proton MR spectroscopy. Radiology 1991; 181: 173-81.
5. Campistol J, Capdevila A, Moreno A. Neuroimagen en la enfermedad de Canavan. Rev Neurol 1995; 23: 920-1.
6. Stöckler S, Holzbach U, Hanefeld F, et al. Creatine deficiency in the brain: a new treatable inborn error of metabolism. Pediatr Res 1994; 36: 409-13.
7. Engelbrecht V, Rassek M, Huismann J, Wendel U. MR and proton MR spectroscopy of the brain in hyperhomocystinemia caused by methylenetetrahydrofolate reductase deficiency. Am J Neurorradiol 1997; 18: 536-9.
8. Ross B, Michaelis T. Clinical applications of magnetic resonance spectroscopy. Magn Reson Q 1994; 10: 191-247.
9. Valk J, Van der Knaap MS. Magnetic resonance of myelin, myelinization and myelin disorders. Berlin: Springer-Werlag; 1988.
10. Lee C, Dineen TE, Breck M, et al. Mucopolysaccharidoses: characterization by cranial MR imaging. Am J Neurorradiol 1993; 14: 1285-92.
11. Kendall BE. Inborn errors and demyelination: MRI and the diagnosis of white matter disease. J Inherit Metab Dis 1993; 16: 771-86.
12. Campistol J, Ribes A, Álvarez L, et al. Glutaric aciduria type I: unusual biochemical presentation. J Pediatr 1992; 121: 83-6.
13. Sperl W, Felber S, Skladal D, Wermuth B. Metabolic stroke in carbamyl phosphate synthetase deficiency. Neuropediatrics 1997; 28: 229-34.
14. Kolschütter A. Neuroradiological and neurophysiological indices for neurometabolic disorders. Eur J Pediatr 1994; 153 (Suppl 1): S90-3.
15. Naidu JB, Moser HW. Value of neuroimaging on metabolic diseases affecting the CNS. Am J Neurorradiol 1991; 12: 403-6.
16. Campistol J, Fernández-Álvarez E, Ruscalleda J. CT appearance of low attenuation areas in basal ganglia in childhood. Report of 23 cases. Comput Radiol 1987; 11: 229-35.
17. Prayer C, Nimberger D, Kramer J, et al. Cranial MRI in Wilson's disease. Neuroradiology 1990; 32: 211-2.
18. Campistol J, Cusi V, Vernet A, Femández-Álvarez E. Dystonia as a presenting sign of subacute necrotizing encephalomyelopathy in infancy. Eur J Pediatr 1986; 144: 589-91.
19. Krägeloh-Mann I, Grodd W, Schöning M, et al. Proton spectroscopy in five patients with Leigh's disease and mitochondrial enzyme deficiency. Dev Med Child Neurol 1993; 35: 769-76.
20. Feliciani M, Curatolo P. Early clinical and imaging (high field MRI) diagnosis of Hallervorden-Spatz disease. Neuroradiology 1994; 36: 247-8.
21. Saivoiardo M, Halliday WC, Nardocci N, et al. Hallervorden-Spatz disease: MR and pathologic findings. Am J Neurorradiol 1993; 14: 155-62.
22. Kuhl DE. Cerebral metabolism and atrophy in Huntington's disease determined by 18 FDG and CT scan. Ann Neurol 1982; 12: 425-31.